Ativan (Lorazepam) - Side Effects and Adverse Reactions

Rx drug information, pharmaceutical research, clinical trials, news, and more

Drugs by Name

Drugs by Condition

Drugs by Category

Alerts

Ativan Rx

Summary Description and Clinical Pharmacology Indications and Dosage Warnings and Precautions Side Effects and Adverse Reactions Drug Interactions, Overdosage and Contraindications Other Rx Information Active Ingredients Adverse Event Reports User Ratings / Reviews

Ativan News

News in Media Published Studies Curr't Clinical Trials

Nutrilib.com A comprihensive source of nutritional information

ADVERSE REACTIONS

Status Epilepticus

The most important adverse clinical event caused by the use of ATIVAN Injection is respiratory depression (see WARNINGS).

The adverse clinical events most commonly observed with the use of ATIVAN Injection in clinical trials evaluating its use in status epilepticus were hypotension, somnolence, and respiratory failure.

Incidence in Controlled Clinical Trials

All adverse events were recorded during the trials by the clinical investigators using terminology of their own choosing. Similar types of events were grouped into standardized categories using modified COSTART dictionary terminology. These categories are used in the table and listings below with the frequencies representing the proportion of individuals exposed to ATIVAN Injection or to comparative therapy.

The prescriber should be aware that these figures cannot be used to predict the frequency of adverse events in the course of usual medical practice where patient characteristics and other factors may differ from those prevailing during clinical studies. Similarly, the cited frequencies cannot be directly compared with figures obtained from other clinical investigators involving different treatment, uses, or investigators. An inspection of these frequencies, however, does provide the prescribing physician with one basis to estimate the relative contribution of drug and nondrug factors to the adverse event incidences in the population studied.

Commonly Observed Adverse Events in a Controlled Dose-Comparison Clinical Trial

Table 1 lists the treatment-emergent adverse events that occurred in the patients treated with ATIVAN Injection in a dose-comparison trial of ATIVAN 1 mg, 2 mg, and 4 mg.

TABLE 1. NUMBER (%) OF STUDY EVENTS IN A DOSE COMPARISON CLINICAL TRIAL

Body System Event ATIVAN Injection (n=130) ¹

Any Study Event (1 or more) ² 16 (12.3%)

Body as a whole

Infection 1 (<1%)

Cardiovascular system

Hypotension 2 (1.5%)

Digestive system

Liver function tests abnormal 1 (<1%)

Nausea 1 (<1%)

Vomiting 1 (<1%)

Metabolic and Nutritional

Acidosis 1 (<1%)

Nervous system

Brain edema 1 (<1%)

Coma 1 (<1%)

Convulsion 1 (<1%)

Somnolence 2 (1.5%)

Thinking abnormal 1 (<1%)

Respiratory system

Hyperventilation 1 (<1%)

Hypoventilation 1 (<1%)

Respiratory failure 2 (1.5%)

Terms not classifiable

Injection site reaction 1 (<1%)

Urogenital system

Cystitis 1 (<1%)

¹ One hundred and thirty (130) patients received ATIVAN Injection.
² Totals are not necessarily the sum of the individual study events because a patient may report two or more different study events in the same body system.

Commonly Observed Adverse Events in Active-Controlled Clinical Trials

In two studies, patients who completed the course of treatment for status epilepticus were permitted to be reenrolled and to receive treatment for a second status episode, given that there was a sufficient interval between the two episodes. Safety was determined from all treatment episodes for all intent-to-treat patients, i.e., from all “patient-episodes.” Table 2 lists the treatment-emergent adverse events that occurred in at least 1% of the patient-episodes in which ATIVAN Injection or diazepam was given. The table represents the pooling of results from the two controlled trials.

TABLE 2. NUMBER (%) OF STUDY EVENTS IN ACTIVE CONTROLLED CLINICAL TRIAL

Body System Event ATIVAN Injection (n=85) ¹ Diazepam (n=80)

Any Study Event (1 or more) ² 14 (16.5%) 11 (13.8%)

Body as a whole

Headache 1 (1.2%) 1 (1.3%)

Cardiovascular system

Hypotension 2 (2.4%) 0

Hemic and lymphatic system

Hypochromic anemia 0 1 (1.3%)

Leukocytosis 0 1 (1.3%)

Thrombocythemia 0 1 (1.3%)

Nervous system

Coma 1 (1.2 %) 1 (1.3%)

Somnolence 3 (3.5%) 3 (3.8%)

Stupor 1 (1.2%) 0

Respiratory system

Hypoventilation 1 (1.2%) 2 (2.5%)

Apnea 1 (1.2%) 1 (1.3%)

Respiratory failure 2 (2.4%) 1 (1.3%)

Respiratory disorder 1 (1.2%) 0

¹ The number indicates the number of “patient-episodes.” Patient-episodes were used rather than “patients” because a total of 7 patients were reenrolled for the treatment of a second episode of status: 5 patients received ATIVAN Injection on two occasions that were far enough apart to establish the diagnosis of status epilepticus for each episode, and, using the same time criterion, 2 patients received diazepam on two occasions.
² Totals are not necessarily the sum of the individual study events because a patient may report two or more different study events in the same body system.

These trials were not designed or intended to demonstrate the comparative safety of the two treatments.

The overall adverse experience profile for ATIVAN was similar between women and men. There are insufficient data to support a statement regarding the distribution of adverse events by race. Generally, age greater than 65 years may be associated with a greater incidence of central-nervous-system depression and more respiratory depression.

Other Events Observed During the Pre-Marketing Evaluation of Ativan Injection for the Treatment of Status Epilepticus

ATIVAN Injection, active comparators, and ATIVAN Injection in combination with a comparator were administered to 488 individuals during controlled and open-label clinical trials. Because of reenrollments, these 488 patients participated in a total of 521 patient-episodes. ATIVAN Injection alone was given in 69% of these patient-episodes (n=360). The safety information below is based on data available from 326 of these patient-episodes in which ATIVAN Injection was given alone.

All adverse events that were seen once are listed, except those already included in previous listings (Table 1 and Table 2).

Study events were classified by body system in descending frequency by using the following definitions: frequent adverse events were those that occurred in at least 1/100 individuals; infrequent study events were those that occurred in 1/100 to 1/1000 individuals.

Frequent and Infrequent Study Events

Body as a Whole - Infrequent: asthenia, chills, headache, infection.

Digestive System - Infrequent: abnormal liver function test, increased salivation, nausea, vomiting.

Metabolic and Nutritional - Infrequent: acidosis, alkaline phosphatase increased.

Nervous System - Infrequent: agitation, ataxia, brain edema, coma, confusion, convulsion, hallucinations, myoclonus, stupor, thinking abnormal, tremor.

Respiratory System - Frequent: apnea; Infrequent: hyperventilation, hypoventilation, respiratory disorder.

Terms Not Classifiable - Infrequent: injection site reaction.

Urogenital System - Infrequent: cystitis.

Preanesthetic

Central Nervous System

The most frequent adverse drug event reported with injectable lorazepam is central-nervous-system depression. The incidence varied from one study to another, depending on the dosage, route of administration, use of other central-nervous-system depressants, and the investigator’s opinion concerning the degree and duration of desired sedation. Excessive sleepiness and drowsiness were the most common consequences of CNS depression. This interfered with patient cooperation in approximately 6% (25/446) of patients undergoing regional anesthesia, causing difficulty in assessing levels of anesthesia. Patients over 50 years of age had a higher incidence of excessive sleepiness or drowsiness when compared with those under 50 (21/106 versus 24/245) when lorazepam was given intravenously (see DOSAGE AND ADMINISTRATION). On rare occasion (3/1580) the patient was unable to give personal identification in the operating room on arrival, and one patient fell when attempting premature ambulation in the postoperative period.

Symptoms such as restlessness, confusion, depression, crying, sobbing, and delirium occurred in about 1.3% (20/1580). One patient injured himself by picking at his incision during the immediate postoperative period.

Hallucinations were present in about 1% (14/1580) of patients and were visual and self-limiting.

An occasional patient complained of dizziness, diplopia and/or blurred vision. Depressed hearing was infrequently reported during the peak-effect period.

An occasional patient had a prolonged recovery room stay, either because of excessive sleepiness or because of some form of inappropriate behavior. The latter was seen most commonly when scopolamine was given concomitantly as a premedicant. Limited information derived from patients who were discharged the day after receiving injectable lorazepam showed one patient complained of some unsteadiness of gait and a reduced ability to perform complex mental functions. Enhanced sensitivity to alcoholic beverages has been reported more than 24 hours after receiving injectable lorazepam, similar to experience with other benzodiazepines.

Local Effects

Intramuscular injection of lorazepam has resulted in pain at the injection site, a sensation of burning, or observed redness in the same area in a very variable incidence from one study to another. The overall incidence of pain and burning in patients was about 17% (146/859) in the immediate postinjection period and about 1.4% (12/859) at the 24-hour observation time. Reactions at the injection site (redness) occurred in approximately 2% (17/859) in the immediate postinjection period and were present 24 hours later in about 0.8% (7/859).

Intravenous administration of lorazepam resulted in painful responses in 13/771 patients or approximately 1.6% in the immediate postinjection period, and 24 hours later 4/771 patients or about 0.5% still complained of pain. Redness did not occur immediately following intravenous injection but was noted in 19/771 patients at the 24-hour observation period. This incidence is similar to that observed with an intravenous infusion before lorazepam is given. Intra-arterial injection may produce arteriospasm resulting in gangrene which may require amputation (see CONTRAINDICATIONS).

Cardiovascular System

Hypertension (0.1%) and hypotension (0.1%) have occasionally been observed after patients have received injectable lorazepam.

Respiratory System

Five patients (5/446) who underwent regional anesthesia were observed to have airway obstruction. This was believed due to excessive sleepiness at the time of the procedure and resulted in temporary hypoventilation. In this instance, appropriate airway management may become necessary (see also CLINICAL PHARMACOLOGY, WARNINGS and PRECAUTIONS).

Other Adverse Experiences

Skin rash, nausea and vomiting have occasionally been noted in patients who have received injectable lorazepam combined with other drugs during anesthesia and surgery.

Paradoxical Reactions

As with all benzodiazepines, paradoxical reactions such as stimulation, mania, irritability, restlessness, agitation, aggression, psychosis, hostility, rage, or hallucinations may occur in rare instances and in an unpredictable fashion. In these instances, further use of the drug in these patients should be considered with caution (see PRECAUTIONS, General).

Postmarketing Reports

Voluntary reports of other adverse events temporally associated with the use of ATIVAN (lorazepam) Injection that have been received since market introduction and that may have no causal relationship with the use of ATIVAN Injection include the following: acute brain syndrome, aggravation of pheochromocytoma, amnesia, apnea/respiratory arrest, arrhythmia, bradycardia, brain edema, coagulation disorder, coma, convulsion, gastrointestinal hemorrhage, heart arrest/failure, heart block, liver damage, lung edema, lung hemorrhage, nervousness, neuroleptic malignant syndrome, paralysis, pericardial effusion, pneumothorax, pulmonary hypertension, tachycardia, thrombocytopenia, urinary incontinence, ventricular arrhythmia.

Fatalities also have been reported, usually in patients on concomitant medications (e.g., respiratory depressants) and/or with other medical conditions (e.g., obstructive sleep apnea).

REPORTS OF SIDE EFFECTS / ADVERSE REACTIONS RELATED TO ATIVAN

Below is a sample of reports where side effects / adverse reactions may be related to Ativan. The information is not vetted and should not be cosidered as verified clinical evidence.

Possible Ativan side effects / adverse reactions in 52 year old male

Reported by a physician from United States on 2007-01-16

Patient: 52 year old male weighing 72.6 kg (159.7 pounds)

Reactions: Thyroid Cancer, Condition Aggravated, Depression, Stress

Adverse event resulted in: hospitalization

Suspect drug(s):
Ativan
    Dosage: 0.5 mg
    Indication: Depression
    Start date: 2006-06-01

Lexapro
    Dosage: 10 mg qd po
    Administration route: Oral
    Indication: Depression
    Start date: 2006-06-01
    End date: 2006-01-01

Lexpro (Escitalopram)
    Dosage: 20 mg qd po
    Administration route: Oral
    Indication: Depression
    Start date: 2006-10-01

Lunesta
    Dosage: 3 mg qhs
    Indication: Insomnia
    Start date: 2006-06-01

Possible Ativan side effects / adverse reactions in 40 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2007-01-22

Patient: 40 year old female

Reactions: Overdose, Intentional Drug Misuse

Adverse event resulted in: hospitalization

Suspect drug(s):
Ativan
Indication: Drug USE FOR Unknown Indication

Cocaine
Indication: Drug USE FOR Unknown Indication

Fentanyl Transdermal System
Administration route: Oral
Indication: Drug USE FOR Unknown Indication

Morphine
Administration route: Oral
Indication: Drug USE FOR Unknown Indication

Possible Ativan side effects / adverse reactions in 53 year old male

Reported by a physician from United States on 2007-01-30

Patient: 53 year old male weighing 72.6 kg (159.7 pounds)

Reactions: Thyroid Cancer, Condition Aggravated, Depression, Stress

Adverse event resulted in: hospitalization

Suspect drug(s):
Ativan
    Dosage: 0.5 mg bid
    Indication: Depression
    Start date: 2006-10-29

Lexapro
    Dosage: 10 mg qd po
    Administration route: Oral
    Indication: Depression
    Start date: 2006-06-01
    End date: 2006-01-01

Lexapro
    Dosage: 20 mg qd po
    Administration route: Oral
    Indication: Depression
    Start date: 2006-10-29

Lunesta
    Dosage: 3 mg qhs
    Indication: Insomnia
    Start date: 2005-10-15
    End date: 2006-01-22

Other drugs received by patient: Asacol; Nexium; Lipitor

Possible Ativan side effects / adverse reactions in 52 year old male

Reported by a physician from United States on 2007-02-01

Patient: 52 year old male weighing 72.6 kg (159.7 pounds)

Reactions: Thyroid Cancer, Condition Aggravated, Depression, Metastases TO Lymph Nodes, Stress

Adverse event resulted in: hospitalization

Suspect drug(s):
Ativan
    Dosage: 0.5 mg; bid
    Indication: Depression
    Start date: 2006-06-01

Lexapro
    Dosage: 10 mg; 20 mg
    Indication: Depression
    Start date: 2006-06-01
    End date: 2006-10-01

Lexapro
    Dosage: 10 mg; 20 mg
    Indication: Depression
    Start date: 2006-10-01

Lunesta
    Dosage: 3 mg; hs; oral
    Administration route: Oral
    Indication: Insomnia
    Start date: 2005-10-15
    End date: 2007-01-22

Other drugs received by patient: Asacol; Nexium; Atorvastatin

Possible Ativan side effects / adverse reactions in 49 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2007-02-05

Patient: 49 year old male

Reactions: Blood Potassium Increased, Epilepsy

Adverse event resulted in: hospitalization

Suspect drug(s):
Ativan
    Dosage: 2.5 mg tid po
    Administration route: Oral
    End date: 2006-01-01

Ativan
    Dosage: df po
    Administration route: Oral
    Start date: 2006-01-01

Ativan
    Dosage: 2.5 mg qid po
    Administration route: Oral
    Start date: 1985-01-01

Other drugs received by patient: Zopiclone

Possible Ativan side effects / adverse reactions in 75 year old female

Reported by a consumer/non-health professional from United States on 2007-02-07

Patient: 75 year old female

Reactions: Cataract, Nausea, Alopecia, Dizziness, Vision Blurred, Decreased Appetite

Adverse event resulted in: disablity

Suspect drug(s):
Ativan
    Dosage: 1 mg tid po
    Administration route: Oral
    Indication: Insomnia
    Start date: 2002-01-01
    End date: 2006-11-01

Ativan
    Dosage: var tid po
    Administration route: Oral
    Indication: Insomnia
    Start date: 2006-11-01

Other drugs received by patient: Prednisone 50mg TAB; Lisinopril

Possible Ativan side effects / adverse reactions in 78 year old male

Reported by a individual with unspecified qualification from United States on 2007-02-08

Patient: 78 year old male

Reactions: Death, Aspiration, Muscular Weakness, Foreign Body Trauma, Stupor

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Ativan
Start date: 2005-10-19

Seroquel
Administration route: Oral
Start date: 2005-10-19

Possible Ativan side effects / adverse reactions in 74 year old male

Reported by a individual with unspecified qualification from United States on 2007-02-08

Patient: 74 year old male weighing 58.0 kg (127.6 pounds)

Reactions: Confusional State, Paralysis, Disorientation, Arrhythmia, Loss of Consciousness, Death, Medication Error, Acute Respiratory Distress Syndrome, Pulse Absent, Bradycardia, Blood Pressure Decreased, Myocardial Infarction, Oxygen Saturation Decreased, Renal Failure Acute

Adverse event resulted in: death

Suspect drug(s):
Ativan
Indication: Agitation

Ativan

Dilaudid
Indication: Pain

Haloperidol
Indication: Confusional State

Possible Ativan side effects / adverse reactions in 44 year old female

Reported by a pharmacist from United States on 2007-02-14

Patient: 44 year old female

Reactions: Burning Sensation, Speech Disorder, Chest Discomfort, Dyspnoea, Skin Discolouration, Hypoaesthesia, Headache, Erythema

Suspect drug(s):
Ambien

Ativan

Cymbalta

Methadone HCL
    Dosage: 30 mg = 3 x 10 mg 2 doses, 3 hrs apart po
    Administration route: Oral
    Indication: Cancer Pain
    Start date: 2007-01-31

Methadone HCL
    Dosage: 30 mg = 3 x 10 mg 2 doses, 3 hrs apart po
    Administration route: Oral
    Indication: Ovarian Cancer
    Start date: 2007-01-31

Morphine Sulfate

Trazodone HCL

Other drugs received by patient: Benadryl; Senokot

Possible Ativan side effects / adverse reactions in 55 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-28

Patient: 55 year old female

Reactions: Head Injury, Encephalopathy, Somnolence, Accidental Overdose, Dysarthria, Haemoglobin Decreased, Asterixis, Atrioventricular Block First Degree, Lethargy, Haematoma

Adverse event resulted in: hospitalization

Suspect drug(s):
Ativan

Other drugs received by patient: Ativan; Epogen; Zemplar; Depakote; Renax; Paxil; Zyprexa; Neurontin; Synthroid; Fosrenol; Sensipar; Renagel

Possible Ativan side effects / adverse reactions in female

Reported by a physician from United States on 2007-03-12

Patient: female

Reactions: Hyperlipidaemia, Diabetes Mellitus, Ovarian Cyst, Blood Triglycerides Increased, Blood Cholesterol Increased, Neuroleptic Malignant Syndrome

Adverse event resulted in: hospitalization

Suspect drug(s):
Abilify
Start date: 2004-01-01
End date: 2005-01-01

Ativan

Buspar

Effexor

Etrafan

Geodon
Start date: 2005-01-01

Lexapro

Paxil

Perphenazine
Start date: 2004-01-01
End date: 2005-01-01

Remeron

Risperdal
Start date: 2004-03-01
End date: 2005-08-01

Seroquel
    Dosage: 100-200 mg
    Administration route: Oral
    Indication: Depression
    Start date: 2005-10-01
    End date: 2005-12-01

Seroquel
    Dosage: 100-200 mg
    Administration route: Oral
    Indication: Mental Disorder
    Start date: 2005-10-01
    End date: 2005-12-01

Thorazine
Start date: 1993-01-01
End date: 1994-01-01

Trazodone HCL

Other drugs received by patient: Lamictal

Possible Ativan side effects / adverse reactions in 53 year old male

Reported by a physician from United States on 2007-03-13

Patient: 53 year old male weighing 72.6 kg (159.7 pounds)

Reactions: Thyroid Cancer, Condition Aggravated, Depression, Stress

Adverse event resulted in: hospitalization

Suspect drug(s):
Ativan
    Dosage: 0.5 mg bid
    Indication: Depression
    Start date: 2006-10-29

Lexapro
    Dosage: 10 mg qd po
    Administration route: Oral
    Indication: Depression
    Start date: 2006-06-01
    End date: 2006-01-01

Lexapro
    Dosage: 20 mg qd po
    Administration route: Oral
    Indication: Depression
    Start date: 2006-10-29

Lunesta
    Dosage: 3 mg qhs
    Indication: Insomnia
    Start date: 2005-10-15
    End date: 2006-01-22

Other drugs received by patient: Asacol; Nexium; Lipitor

Possible Ativan side effects / adverse reactions in 57 year old female

Reported by a individual with unspecified qualification from United States on 2007-03-20

Patient: 57 year old female weighing 74.8 kg (164.7 pounds)

Reactions: Drug Effect Decreased, Headache, Muscle Rigidity, Panic Disorder, Convulsion, Anxiety, Myalgia, Musculoskeletal Stiffness, Pharmaceutical Product Complaint, Fluid Retention

Suspect drug(s):
Ativan
    Dosage: as needed 6 mg per day
    Indication: Anxiety
    Start date: 2006-02-01

Ativan
    Dosage: as needed 6 mg per day
    Indication: Panic Attack
    Start date: 2006-02-01

Possible Ativan side effects / adverse reactions in 17 year old female

Reported by a consumer/non-health professional from United States on 2007-03-23

Patient: 17 year old female weighing 56.8 kg (125.0 pounds)

Reactions: Agitation, Akathisia, Flat Affect, Depersonalisation, Intentional Overdose, Nausea, Abnormal Behaviour, Suicidal Ideation, Tremor, Anxiety, Social Avoidant Behaviour, Insomnia, Mental Disorder, Suicide Attempt

Adverse event resulted in: hospitalization

Suspect drug(s):
Ativan
Dosage: 2tab single dose

Benadryl
Dosage: 2tab single dose

Paxil
    Dosage: 10mg twice per day
    Administration route: Oral
    Indication: Depression
    Start date: 2002-09-26
    End date: 2003-01-01

Tylenol
Dosage: 4tab single dose
Administration route: Oral

Other drugs received by patient: Chemotherapy; Methotrexate; Purinethol; Ventolin; Bactrim; ALL Trans Retinoic Acid

Possible Ativan side effects / adverse reactions in 35 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2007-03-23

Patient: 35 year old female

Reactions: Intentional Overdose

Adverse event resulted in: death

Suspect drug(s):
Ativan
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication

Flexeril
Dosage: unk, unk
Indication: Drug USE FOR Unknown Indication

Oxycontin
    Dosage: 80 mg, bid
    Administration route: Oral
    Indication: Drug USE FOR Unknown Indication

Percocet
    Dosage: unk, see text
    Indication: Drug USE FOR Unknown Indication
    Start date: 2007-01-23

Possible Ativan side effects / adverse reactions in 61 year old female

Reported by a consumer/non-health professional from United States on 2007-04-04

Patient: 61 year old female weighing 70.3 kg (154.7 pounds)

Reactions: Pruritus, Drug Ineffective, Pain, Thirst, Constipation, Hyperhidrosis, Fatigue, DRY Mouth, Hallucination, Muscle Spasms, Chest Discomfort, Dyspnoea, Drug Hypersensitivity, Rash, Heart Rate Increased, Insomnia, Memory Impairment, Pharmaceutical Product Complaint, Asthenia

Adverse event resulted in: life threatening event, disablity

Suspect drug(s):
Ativan
    Dosage: 1 mg tid po
    Administration route: Oral
    Indication: Anxiety
    End date: 2007-03-18

Ativan
    Dosage: 1 mg tid po
    Administration route: Oral
    Indication: Cardiac Disorder
    End date: 2007-03-18

Ativan
    Dosage: 1 mg tid po
    Administration route: Oral
    Indication: Anxiety

Ativan
    Dosage: 1 mg tid po
    Administration route: Oral
    Indication: Cardiac Disorder

Other drugs received by patient: Toprol-XL

Possible Ativan side effects / adverse reactions in 39 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2007-04-04

Patient: 39 year old female weighing 80.7 kg (177.5 pounds)

Reactions: Confusional State, Contusion, Subcutaneous Abscess, Pleural Adhesion, Fall, Drug Toxicity, Panniculitis, Cerebral Infarction, Dehydration, Hepatic Congestion, Thyroiditis Chronic, Myocardial Fibrosis, Gastroenteritis Viral

Adverse event resulted in: death

Suspect drug(s):
Ativan
Indication: Drug USE FOR Unknown Indication

Benadryl
Indication: Drug USE FOR Unknown Indication

Klonopin
Indication: Drug USE FOR Unknown Indication

Noctec
Administration route: Oral
Indication: Insomnia

Robaxin
Indication: Drug USE FOR Unknown Indication

Soma
Indication: Drug USE FOR Unknown Indication

Tamiflu
Administration route: Oral
Start date: 2007-02-05

Valium
Indication: Drug USE FOR Unknown Indication

Other drugs received by patient: Methadone HCL; Nutropin; Vitamin B-12; Immunoglobulin Injectable; Cipro; Topamax; Acetaminophen

Possible Ativan side effects / adverse reactions in 78 year old male

Reported by a individual with unspecified qualification from United States on 2007-04-09

Patient: 78 year old male

Reactions: Death, Aspiration, Muscular Weakness, Foreign Body Trauma, Stupor

Adverse event resulted in: death, hospitalization

Suspect drug(s):
Ativan
Start date: 2005-10-19

Seroquel
Administration route: Oral
Start date: 2005-10-19

Possible Ativan side effects / adverse reactions in 75 year old female

Reported by a physician from United States on 2007-04-13

Patient: 75 year old female weighing 75.3 kg (165.7 pounds)

Reactions: Cataract, Nausea, Alopecia, Vision Blurred, Hypertension, Decreased Appetite

Adverse event resulted in: disablity

Suspect drug(s):
Ativan
    Dosage: 1 mg tid; po
    Administration route: Oral
    Indication: Anxiety Disorder
    Start date: 1996-01-01
    End date: 2006-11-01

Ativan
    Dosage: 1 mg tid; po
    Administration route: Oral
    Indication: Insomnia
    Start date: 1996-01-01
    End date: 2006-11-01

Ativan
    Dosage: var tid; po
    Administration route: Oral
    Indication: Anxiety Disorder
    Start date: 2006-11-01

Ativan
    Dosage: var tid; po
    Administration route: Oral
    Indication: Insomnia
    Start date: 2006-11-01

Other drugs received by patient: Prednisone TAB; Lisinopril

Possible Ativan side effects / adverse reactions in 57 year old male

Reported by a individual with unspecified qualification from United Kingdom on 2007-04-16

Patient: 57 year old male

Reactions: Ventricular Extrasystoles, Dyspnoea, Tachycardia, Somnolence

Suspect drug(s):
Ativan
Dosage: 1 mg prn po
Administration route: Oral

Zaponex
    Dosage: 12.5 mg q day po
    Administration route: Oral
    Indication: Schizophrenia
    Start date: 2006-03-17
    End date: 2006-03-24

Other drugs received by patient: Valproic Acid

See index of all Ativan side effect reports >>

Drug label data at the top of this Page last updated: 2008-01-18

-- advertisement --

We comply with
HONcode standard.
Verify here.

Home | About Us | Contact Us | Site usage policy | Privacy policy